SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

INOs FDA approval is prompting traders to speculate that the agency may be more receptive to rare-disease treatments, lifting attention on Capricor ahead of deramiocels FDA decision for Duchenne muscular dystrophy. The community is divided: some see the approval, recent data and launch-related hiring as encouraging signals, while others stress that CAPRs outcome is uncertain given prior FDA concerns and debate over the evidence.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure in a sharp semiconductor selloff as traders question whether heavy AI infrastructure spending will deliver sufficient returns, with weak Intel guidance and Amazons elevated capital spending adding to tech-sector jitters. The community is divided between warnings that AI-related investment and financing risks could prolong the decline and dip buyers pointing to strong demand and oversold conditions.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put Precigens PAPZIMEOS in focus, prompting debate over the threat of new competition. Some traders worry about market share, while others argue Precigens first-mover advantage, commercial launch, and full approval temper the risk compared with Inovios accelerated approval.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report, fueled by demand for Mounjaro and Zepbound and a higher full-year revenue outlook, is driving LLYs rally and analyst upgrades. Bullish traders point to continued obesity-drug growth, while skeptics flag the trimmed profit outlook and high valuation.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline significantly during 2027 has fueled a sharp selloff, raising concerns about pricing and CorMedixs largest revenue driver. Traders disagree over whether DaVitas preliminary outlook signals lasting pressure, pointing to CMSs more reassuring payment estimate and arguing the reaction may be excessive.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by growth in Eylea HD and Sanofi collaboration sales from Dupixent, are driving attention. Traders are broadly bullish on the sharp rally and breakout, while some are weighing whether the gains can be sustained.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is drawing attention after a sharp selloff tied to Brazils election results and broader weakness in Brazilian-linked stocks. Traders disagree over whether political and market risks signal further downside or create a buying opportunity, with some pointing to the companys continued growth ahead of earnings.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas stronger-than-expected quarterly results and cost-savings plan to support drug development are driving attention, alongside CEO optimism about its pipeline. Traders are reacting to the sharp rise and move above the 200-day average with broadly bullish commentary.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Robloxs quarterly results beat estimates, but declining user activity and a forecast for lower fourth-quarter bookings have driven a sharp selloff. Traders are largely bearish over slowing growth and monetization, while some view the drop as an overreaction and a buying opportunity.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas earnings beat and raised outlook, alongside its positioning as an identity-security layer for AI agents, have fueled a sharp cybersecurity-led rally. Traders are divided over whether demand can justify the valuation, with some taking profits or betting on a pullback after the run-up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UNDERCOVER SNACKS ANNOUNCES MAJORITY INVESTMENT BY MONDELZ INTERNATIONAL

UNDERCOVER SNACKS ANNOUNCES MAJORITY INVESTMENT BY MONDELZ INTERNATIONAL UNDERCOVER SNACKS ANNOUNCES MAJORITY INVESTMENT BY MONDELZ INTERNATIONALPR NewswireEAST HANOVER, N.J., Oct. 30, 2026 Partnership with global snacking leader will help accelerate Undercover's growth, innovation and reach while...

Mondelez Q3 Earnings Beat Estimates on Lower Costs, Revenues Miss

Mondelez's Q3 2026 earnings beat estimates on lower costs and stronger margins, while revenues miss despite volume gains. The company reaffirms its 2026 outlook.


Futures Slide As AI Reckoning Claims Amazon, Intel; Oil Jumps On Hormuz Tanker Hits

Futures Slide As AI Reckoning Claims Amazon, Intel; Oil Jumps On Hormuz Tanker Hits

 US futures slide with Nasdaq futures tumbling more than 2%, as the AI reckoning that started with Alphabet's record plunge claims two more megacaps: Amazon slides after a capex shock and the slowest...

Mondelez International Q3 2026 Earnings Call Transcript

Mondelez International (NASDAQ:MDLZ) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you byread more...

Mondelez (MDLZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Mondelez (MDLZ) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Mondelez (MDLZ) Beats Q3 Earnings Estimates

Mondelez (MDLZ) delivered earnings and revenue surprises of +8.33% and -0.10%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Sysco (SYY) Earnings Expected to Grow: Should You Buy?

Sysco (SYY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ahead of Mondelez (MDLZ) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Mondelez (MDLZ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.

Mondelez Readies for Q3 Earnings: Key Things to Watch for MDLZ

Mondelez's Q3 2026 earnings may reflect stronger snacking demand, improving volumes and emerging market growth, though inflation and rising costs pose risks.


Earnings Preview: Mondelez (MDLZ) Q3 Earnings Expected to Decline

Mondelez (MDLZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

$MDLZ Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.78 up 6.85% YoY
• Reported revenue of $9.97B up 2.29% YoY
• Mondelz International reaffirms 2026 Organic Net Revenue growth of at least 2% and Adjusted EPS growth, flat to 5% on a constant currency basis; 2026 Free Cash Flow is approximately $3B.

Stocktwits

Mondelez International Inc. - Ordinary Shares - Class A

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.78 up 6.85% YoY
• Reported revenue of $9.97B up 2.29% YoY
• Mondelz International reaffirms 2026 Organic Net Revenue growth of at least 2% and Adjusted EPS growth, flat to 5% on a constant currency basis; 2026 Free Cash Flow is approximately $3B.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $0.78 up 6.85% YoY
• Reported revenue of $9.97B up 2.29% YoY
• Mondelz International reaffirms 2026 Organic Net Revenue growth of at least 2% and Adjusted EPS growth, flat to 5% on a constant currency basis; 2026 Free Cash Flow is approximately $3B.

Mondelz International reported Europe Organic Net Revenue of (2.1)% and pricing of (3.7) pp; year-to-date constant-currency adjusted earnings were lower, amid greater than usual volatility including geopolitical, trade and regulatory uncertainty and commodity prices.

Mondelz International posted 2.1% Organic Net Revenue growth on favorable volume/mix and higher pricing, increased Adjusted Gross Profit margin through productivity and lower costs, and agreed to acquire Undercover Snacks.

Mondelez International, Inc. engages in the manufacture and marketing of snack food and beverage products. Its products include beverages, biscuits, chocolate, gum and candy, cheese and groceries, and meals. Its brands include 5Star, 7Days, Alpen Gold, Barni, Belvita, Bournvita, Cadbury, Cadbury Dairy Milk, Chips Ahoy! Clif, Clorets, Club Social, Côte d'Or, Daim, Enjoy Life Foods, Freia, Grenade, Halls, Honey Maid, Hu, Kinh Do, Lacta, Lu, Marabou, Maynards Bassett’s, Mikado, Milka, Oreo, Perfect Snacks, Philadelphia, Prince, Ritz, Royal, Sour Patch Kids, Stride, Tang, Tate’s Bake Shop, Tiger, Toblerone, Triscuit, TUC, and Wheat Thins. It operates through the following geographical segments: Latin America, Asia, Middle East, and Africa, Europe, and North America. The company was founded by James Lewis Kraft in 1903 is headquartered in Chicago, IL.

Why Did KO, MDLZ, TGT Stocks Hit 52-Week Highs Today?  

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Coca-Cola shares reached a record $90.92 after strong Q2 results boosted investor confidence.&nbsp;</li><li>Strong demand for Mondelēz's brands like Oreo, Ritz and Cadbury, along with cost management efforts, improved investor sentiment.&nbsp;</li><li>Target shares reached a 20-month high of $147.77 as stronger inventory management boosted confidence ahead of Q2 earnings.&nbsp;</li></ul>The Coca-Cola Co. (KO), Mondelēz International (MDLZ), and Target Corp. (TGT) stocks reached fresh 52-week highs on Wednesday, benefiting from strong quarterly results and renewed confidence in defensive consumer stocks as investors shifted toward businesses with steady demand, strong brands and reliable cash generation.&nbsp;The stock performance reflected investor preference for resilient earnings as some technology companies faced questions over spending levels and capital requirements.<h2 class="st-heading-2">Coca-Cola Gains From Demand Strength</h2><a href="https://stocktwits.com/symbol/KO">Coca-Cola stock</a> climbed to a record high of $90.92 after reporting stronger-than-expected second-quarter (Q2) results on Tuesday. Global marketing efforts, including FIFA World Cup-related campaigns, helped boost demand for its flagship brands.Wall Street analysts&nbsp;have turned more confident about the company’s business, with&nbsp;brokerages raising their price targets while pointing to the beverage giant’s pricing strength, global reach and resilient business model.Morgan Stanley analyst Dara Mohsenian lifted the price target on KO to $100 from $89 while maintaining an ‘Overweight’ rating. Mohsenian said the Q2 results reinforced Coca-Cola’s competitive advantages and demonstrated that the company has maintained stronger pricing capabilities than many consumer packaged goods rivals. RBC Capital also raised its outlook for Coca-Cola, increasing its price target to $96 from $87 while keeping an ‘Outperform’ rating.&nbsp;On Stocktwits, retail sentiment around the stock turned‘bullish’ from ‘extremely bullish’ the previous day.&nbsp;<h2 class="st-heading-2">Mondelēz Defends Margins</h2><a href="https://stocktwits.com/symbol/MDLZ">Mondelēz International stock</a> reached an annual high of $66.65 after the snacks company delivered Q2 adjusted earnings of $0.73 per share on $9.36 billion in revenue, supported by continued demand for brands such as Oreo, Ritz and Cadbury.The company offset cocoa cost pressures through supply chain improvements, and hedging strategies, lifting sentiment. Wall Street analysts turned optimistic as well, citing improved sales trends, better market performance and continued investment in its brands supporting a more positive outlook for Mondelēz.Goldman Sachs analyst Leah Jordan increased the price target on Mondelēz to $72 from $65 while keeping a ‘Buy’ rating on the stock. Jordan said the company’s Q2 benefited from stronger performance in North America and improving volume trends, while brand spending could help maintain momentum through the second half of 2026 and into 2027.Retail sentiment around the stock changed to ‘neutral’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">Target Shows Turnaround Progress</h2><a href="https://stocktwits.com/symbol/TGT">Target stock</a> touched a twenty-month high of $147.77 as shoppers responded to improved inventory levels, competitive pricing and stronger store traffic ahead of its Q2 earnings on August 19.&nbsp;Last week, Guggenheim increased its price target for Target to $150 from $145 and kept a ‘Buy’ rating on the stock. The firm believes Target still has major opportunities ahead through store renovations and improvements to its product selection. The analyst said Target is showing a clearer path toward earning more than $9 per share in 2027.&nbsp;&nbsp;Retail sentiment around the stock remained in ‘bullish’ territory.&nbsp;So far this year, MDLZ and KO stocks gained 20% and 27% respectively, while TGT stock has climbed 49%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/default/equity/cmg-stock-jumps-overnight-honey-chicken-chipotlanes-and-ai-fuel-fresh-growth-hopes/cZNPZHmRJTu">CMG Stock Jumps Overnight: Honey Chicken, Chipotlanes And AI Fuel Fresh Growth Hopes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bags of Oreos sit on shelves at a Target store in Austin, Texas. 

Investors leaned toward companies that can protect margins, and maintain customer loyalty.

Why Did KO, MDLZ, TGT Stocks Hit 52-Week Highs Today?

Investors leaned toward companies that can protect margins and maintain customer loyalty. 


Coca-Cola Co

Target Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$64.94
Prev Close	$62.53
Open	$65.00
Dividend Yield	3.60%
50-Day Moving Average	$61.78
Beta	0.03
Avg. Volume	8.14M
PE Ratio	22.94

52-Week High	$66.65
52-Week Low	$51.20
Market Capitalization	$79.81B
EPS (Annual)	$1.89
Price to Book	3.01
Revenue Per Employee	$423,483.52

Feed

News

Sentiment

Earnings

Fundamentals

Info

MDLZ Fundamentals